Molecular and Clinical characteristics of ROS1 Fusion Variants in ROS1-rearranged Cancers: A Defined Role of Fusion Partners and Breakpoints of ROS1. (2025)
Attributed to:
Understanding and targeting oncogenic biomolecular condensates of ALK kinase
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ejca.2025.116091
PubMed Identifier: 41205256
Publication URI: http://europepmc.org/abstract/MED/41205256
Type: Journal Article/Review
Volume: 231
Parent Publication: European journal of cancer (Oxford, England : 1990)
ISSN: 0959-8049